☰

Theresa T. Crocker, Ph.D. - Publications

Affiliations: 
2013 Anthropology University of South Florida, Tampa, FL, United States 
Area:
Cultural Anthropology
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Kumar NB, Pow-Sang J, Egan KM, Spiess PE, Dickinson S, Salup R, Helal M, McLarty JW, Williams CR, Schreiber F, Parnes HL, Sebti S, Kazi A, Kang L, Quinn GP, ... ... Crocker T, et al. Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention. Cancer Prevention Research (Philadelphia, Pa.). PMID 25873370 DOI: 10.1158/1940-6207.Capr-14-0324  0.453
2015 Kumar NB, Pow-Sang J, Egan K, Spiess PE, Dickinson SI, Salup R, Helal M, McLarty J, Williams CR, Schreiber FJ, Parnes H, Sebti S, Kazi A, Kang L, Quinn GP, ... ... Crocker T, et al. Effect of green tea catechins in prostate cancer chemoprevention. Journal of Clinical Oncology. 33: 1572-1572. DOI: 10.1200/Jco.2015.33.15_Suppl.1572  0.447
2015 Kumar NB, Pow-Sang J, Egan KM, Spiess PA, Dickinson S, Salup R, Helal M, McLarty J, Williams CR, Schreiber F, Sebti S, Kazi A, Kang L, Quinn G, Smith T, ... ... Crocker T, et al. Abstract PR06: Effect of polyphenon E on progression to prostate cancer after diagnosis of high grade prostatic intraepithelial neoplasia Cancer Prevention Research. 8. DOI: 10.1158/1940-6215.Prev-14-Pr06  0.454
2012 Kumar N, Crocker T, Smith T, Connors S, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, et al. Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome Measures. Journal of Clinical Trials. 2. PMID 24533253 DOI: 10.4172/Jctr.1000105  0.451
2012 Kumar N, Crocker T, Smith T, Pow-Sang J, Spiess PE, Connors S, Chornukur G, Dickinson SI, Bai W, Williams CR, Salup R, Fu W. Prostate Cancer Chemoprevention Targeting High Risk Populations: Model for Trial Design and Outcome Measures. Journal of Cancer Science & Therapy. 2011. PMID 22422102 DOI: 10.4172/1948-5956.S3-007  0.433
2012 Kumar N, Crocker T, Smith T, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, Trabulsi E, et al. Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer. Contemporary Clinical Trials. 33: 279-85. PMID 22101219 DOI: 10.1016/J.Cct.2011.11.004  0.429
2012 Kumar NB, Quinn GP, Crocker T, Alexandrow M, Gray JE, Estrella T, Schell MJ, Sutton S, Haura EB. Assessment of feasibility and willingness of former heavy smokers to participate in chemoprevention trials to prevent lung cancer. Journal of Clinical Oncology. 30: e21155-e21155. DOI: 10.1200/Jco.2012.30.15_Suppl.E21155  0.37
2010 Kumar NB, Kazi A, Smith T, Crocker T, Yu D, Reich RR, Reddy K, Hastings S, Exterman M, Balducci L, Dalton K, Bepler G. Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment. Current Treatment Options in Oncology. 11: 107-17. PMID 21128029 DOI: 10.1007/S11864-010-0127-Z  0.327
Show low-probability matches.